@prefix config: . @prefix meta: . @prefix rdf: . @prefix rdfs: . @prefix xsd: . @prefix owl: . @prefix dc: . @prefix dcmitype: . @prefix dcterms: . @prefix foaf: . @prefix geo: . @prefix om: . @prefix locn: . @prefix schema: . @prefix skos: . @prefix dbpedia: . @prefix p: . @prefix yago: . @prefix units: . @prefix geonames: . @prefix prv: . @prefix prvTypes: . @prefix doap: . @prefix void: . @prefix ir: . @prefix ou: . @prefix teach: . @prefix time: . @prefix datex: . @prefix aiiso: . @prefix vivo: . @prefix bibo: . @prefix fabio: . @prefix vcard: . @prefix swrcfe: . @prefix frapo: . @prefix org: . @prefix ei2a: . @prefix pto: . vivo:identifier "2002-203"; bibo:issn "0009-9236"; dcterms:publisher "Clinical Pharmacology and Therapeutics"; bibo:doi "10.1067/mcp.2002.121788"; a ou:Publicacion; dcterms:creator "Christensen M."; dcterms:title "Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)"; fabio:hasPublicationYear "2002"; vcard:url ; ou:eid "2-s2.0-0036212577"; ou:urlOrcid ; ou:vecesCitado "82"; dcterms:contributor "Christensen, M., Tybring, G., Mihara, K., Yasui-Furokori, N., Carrillo, J.A., Ramos, S.I., Andersson, K., Dahl, M.-L., Bertilsson, L."; bibo:page_range "141-152"; ou:tipoPublicacion "Article"; bibo:volume "71"; ou:bibtex "@article{Carrillo Norte2002,title = {Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19)},journal = {Clinical Pharmacology and Therapeutics},year = {2002},volume = {71},number = {3},pages = {141-152},author = {Christensen, M. and Tybring, G. and Mihara, K. and Yasui-Furokori, N. and Carrillo, J.A. and Ramos, S.I. and Andersson, K. and Dahl, M.-L. and Bertilsson, L.}}"; ou:urlScopus . ou:tienePublicacion .